Skip to main content
English
中文
Log In
Log in
Log in with ORCID
NTU Single Sign On
New user? Click here to register.
Have you forgotten your password?
Home
.National Taiwan University / 國立臺灣大學
Project / 研究計畫
Development of Hbhac-Modified Infliximab with Transcytosis Ability for Inflammatory Bowel Disease by Oral Delivery System
Development of Hbhac-Modified Infliximab with Transcytosis Ability for Inflammatory Bowel Disease by Oral Delivery System
Details
Primary Data
Project title
發展經HBHAc修飾且具有穿胞能力之抗體藥物infliximab,用於發炎性大腸疾病之口服遞送系統
Internal ID
MOST108-2320-B002-056
Principal Investigator
LI-JIUAN SHEN
Start Date
August 1, 2019
End Date
July 31, 2020
Organizations
Clinical Pharmacy
Partner Organizations
National Science and Technology Council
Description
Keywords
發炎性大腸疾病
infliximab
抗體藥物口服遞送
穿胞胜肽
inflammatory bowel disease
infliximab
antibody drug oral delivery
cell-penetrating peptide